Synonyms Disorder, Vascular Hemostatic, Disorders, Vascular Hemostatic, Hemostatic Disorder + [17] |
Introduction Pathological processes involving the integrity of blood circulation. Hemostasis depends on the integrity of BLOOD VESSELS, blood fluidity, and BLOOD COAGULATION. Majority of the hemostatic disorders are caused by disruption of the normal interaction between the VASCULAR ENDOTHELIUM, the plasma proteins (including BLOOD COAGULATION FACTORS), and PLATELETS. |
Target |
Mechanism BCMA modulators |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date23 Feb 2024 |
Target- |
Mechanism Fibrinogen stimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. KR |
First Approval Date16 Feb 2024 |
Target |
Mechanism γ-secretase inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date27 Nov 2023 |
Start Date01 Jan 2025 |
Sponsor / Collaborator Aytu Biopharma, Inc. [+1] |
Start Date16 Nov 2024 |
Sponsor / Collaborator |
Start Date01 Sep 2024 |
Sponsor / Collaborator |